News
Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England ...
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...
4d
Clinical Trials Arena on MSNFDA Commissioner envisions fewer delays, more clinical trial flexibility and AI useFDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.
Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...
FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...
4d
The Mirror US on MSNFDA to fast-track drug approvals for companies pushing ‘national priorities’ in major overhaulFood and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...
2d
Pharmaceutical Technology on MSNFDA cell and gene therapy director exit increases ‘volatility’ for sectorNicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results